Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease (Q44781843)
Jump to navigation
Jump to search
scientific article published on 16 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease |
scientific article published on 16 June 2012 |
Statements
1 reference
Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease (English)
1 reference
W J Sandborn
1 reference
J F Colombel
1 reference
S Schreiber
1 reference
W Reinisch
1 reference
D W Hommes
1 reference
A M Robinson
1 reference
B Huang
1 reference
K G Lomax
1 reference
P F Pollack
1 reference
16 June 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference